FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved the supplemental application for Lipofen (fenofibrate) submitted by ANI Pharmaceuticals, Inc., granting regulatory approval for the requested c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• LIPOFEN (FENOFIBRATE)

Snippet

SUPPL AP for LIPOFEN (FENOFIBRATE)